Day: December 9, 2013


GA101 clinical trail press release…

Posted on 9 December 2013 by Paul Brennan

There was a nice story on the BBC today about GA101, a new antibody targeting CD20 which is being used to treat CLL. Our own, Professor Chris Fegan gave quotes for the BBC article. The press release follows very promising results showing that GA101 works better than MabThera/Rituxan as reported in last summer’s press release from
Read more